Informação sobre produto
Nome:Decernotinib (VX-509)
Marca:Biosynth
Descrição:Decernotinib is a small molecule inhibitor that binds to the ATP site of the polymerase chain reaction (PCR) enzyme. Decernotinib has shown efficacy in animal models of autoimmune diseases, such as alopecia areata and rheumatoid arthritis. It has also been shown to inhibit the response of primary cells isolated from patients with systemic lupus erythematosus and myasthenia gravis. The drug is expected to be used as an antirheumatic drug for the treatment of inflammatory diseases. Decernotinib has not yet been tested in humans, but it is predicted that this drug will have few side effects and no significant interactions with other drugs.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:392.38 g/mol
Fórmula:C18H19F3N6O
Pureza:Min. 95%